Calciphylaxis in a dialysis patient treated by intralesional and systemic sodium thiosulphate on top of...

Area of Science:

• Nephrology
• Dermatology
• Vascular Medicine

Background:

• Calciphylaxis (calcific uremic arteriolopathy, CUA) is a rare, life-threatening vasculopathy.
• Patients with end-stage renal disease on dialysis and those on warfarin are at increased risk.
• Current treatments for CUA are limited, with poor patient survival rates.

Purpose of the Study:

• To evaluate the efficacy of a multipronged treatment approach for calciphylaxis.
• To assess the combined use of intravenous and intralesional sodium thiosulphate (STS) in a hemodialysis patient with CUA.

Main Methods:

• A single hemodialysis patient diagnosed with calciphylaxis was treated.
• The intervention involved a combination of intravenous and intralesional administration of sodium thiosulphate (STS).

Main Results:

• The patient demonstrated significant improvement in CUA-related wounds.
• The multipronged approach utilizing both intravenous and intralesional STS was associated with positive wound healing outcomes.

Conclusions:

• Combined intravenous and intralesional sodium thiosulphate may represent a viable treatment strategy for calciphylaxis.
• This approach could offer an alternative for managing CUA, particularly in patients with limited therapeutic options.